Final Study Report: Sources of Financing and Policy Recommendations on Boosting eHealth Investment

Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth InvestmentThe Financing eHealth study was commissioned by DG INFSO and Media's ICT for Health Unit. The aim is to assess different financing opportunities against the financing needs of eHealth investment. The overriding goal of the study, and of this final report, is to assist Member States and the European Commission (EC) in their efforts to meet the eHealth Action Plan objective of "supporting and boosting investment in eHealth".

A sobering conclusion of the study is that just increasing finance for eHealth will not necessarily boost investment. How much to spend is the wrong question and conveys an inappropriate perspective. What to spend the money spent on is a better question. The most important part of eHealth investment that needs expanding is the eHealth skills and knowledge of healthcare staff and ICT suppliers' staff. An expanded capability is essential to achieve more success and so help to boost eHealth investment.

Increased capability helps to secure the potential and confidence that eHealth will add enough value. If an investment is worth it, providing the required finance becomes a supporting priority. Denying finance for eHealth is the right decision where the planned investment does not show a better net benefit than other types of competing investment. Choosing the best financing arrangement is a challenge for eHealth investors. A common theme seems to be the difficulty in integrating eHealth financing into the factors that ensure success. Over-emphasising finance for ICT to the detriment of engagement, change, and benefits realisation may be prevalent, and needs correcting.

No single source of financing is enough to initiate an eHealth investment and see it through to its completion. Mixed financing arrangements are a solution to handle such investments at all stages of their lifecycle. This applies to both recurring and nonrecurring costs. Joint financing for recurring costs is a model in which all beneficiaries have to be involved in the financing stage. Current financing opportunities support a limited, and often insufficient, time-period of the investment lifecycle. Therefore a combination of sources is suitable to support an investment, and its characteristics determine the finance mix. Often, different models of eHealth financing need combining to procure such investments.

Download Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth Investment Final study report (.pdf, 847 KB).

Download from the eHealthNews.EU Portal's mirror: Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth Investment Final study report (.pdf, 847 KB).

For further information, please visit:
http://www.financing-ehealth.eu

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

About Financing eHealth study
The Financing eHealth study was commissioned by DG INFSO and Media, unit ICT for Health, with the aim to assess different financing opportunities against the financing needs of eHealth investment. The overriding goal is to provide assistance to Member States and the European Commission in their efforts to meet the eHealth Action Plan objective of "supporting and boosting investment in eHealth".

The study focuses on providing insights and specific recommendations on:

  • developing the supply side of eHealth finance to optimise the use of resources available for boosting investment in eHealth, including ways to add value through collaboration between Member States;
  • effective and efficient management of eHealth investment to support health services providers, i.e. the demand side.

These recommendations aim to help close the gap between supply of and demand for eHealth financing, and thus support Member States and the European Commission in their activities.

For further information, please visit http://www.financing-ehealth.eu.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...